These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28558415)

  • 1. Obstacles to reducing plasma levels of uremic solutes by hemodialysis.
    Sirich TL
    Semin Dial; 2017 Sep; 30(5):403-408. PubMed ID: 28558415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Treatment Duration and Frequency on Uremic Solute Kinetics, Clearances and Concentrations.
    Leypoldt JK; Meijers BK
    Semin Dial; 2016 Nov; 29(6):463-470. PubMed ID: 27578429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic toxicity: urea and beyond.
    Depner TA
    Semin Dial; 2001; 14(4):246-51. PubMed ID: 11489197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial.
    Luo FJ; Patel KP; Marquez IO; Plummer NS; Hostetter TH; Meyer TW
    Am J Kidney Dis; 2009 Jun; 53(6):1042-9. PubMed ID: 19394728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
    Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
    Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of residual function to removal of protein-bound solutes in hemodialysis.
    Marquez IO; Tambra S; Luo FY; Li Y; Plummer NS; Hostetter TH; Meyer TW
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):290-6. PubMed ID: 21030575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.
    Meyer TW; Sirich TL; Fong KD; Plummer NS; Shafi T; Hwang S; Banerjee T; Zhu Y; Powe NR; Hai X; Hostetter TH
    J Am Soc Nephrol; 2016 Nov; 27(11):3469-3478. PubMed ID: 27026365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.
    Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
    Kidney Int; 2003 Dec; 64(6):2238-43. PubMed ID: 14633148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
    Sirich TL; Fong K; Larive B; Beck GJ; Chertow GM; Levin NW; Kliger AS; Plummer NS; Meyer TW;
    Kidney Int; 2017 May; 91(5):1186-1192. PubMed ID: 28089366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic Toxin Clearance and Cardiovascular Toxicities.
    Mair RD; Sirich TL; Meyer TW
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29865226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whither goest Kt/V?
    Gotch FA; Sargent JA; Keen ML
    Kidney Int Suppl; 2000 Aug; 76():S3-18. PubMed ID: 10936795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.
    Leong SC; Sao JN; Taussig A; Plummer NS; Meyer TW; Sirich TL
    J Am Soc Nephrol; 2018 Jul; 29(7):1992-1999. PubMed ID: 29728422
    [No Abstract]   [Full Text] [Related]  

  • 14. Removal of Uremic Solutes from Dialysate by Activated Carbon.
    Lee S; Sirich TL; Blanco IJ; Plummer NS; Meyer TW
    Clin J Am Soc Nephrol; 2022 Aug; 17(8):1168-1175. PubMed ID: 35835518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.
    Evenepoel P; Bammens B; Verbeke K; Vanrenterghem Y
    Kidney Int; 2006 Aug; 70(4):794-9. PubMed ID: 16820785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
    Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
    Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of P-cresol sulfate by hemodialysis.
    Martinez AW; Recht NS; Hostetter TH; Meyer TW
    J Am Soc Nephrol; 2005 Nov; 16(11):3430-6. PubMed ID: 16120820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sad but forgotten truth: the story of slow-moving solutes in fast hemodialysis.
    Eloot S; Van Biesen W; Vanholder R
    Semin Dial; 2012; 25(5):505-9. PubMed ID: 22925227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intradialytic exercise on hemodialysis adequacy: A systematic review.
    Kirkman DL; Scott M; Kidd J; Macdonald JH
    Semin Dial; 2019 Jul; 32(4):368-378. PubMed ID: 30968465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.